Name

Jelmyto

Alternate Names

mitomycin gel

Abbreviations

None

Category

Chemotherapy

Subcategory

Alkylating agent
anti neoplastic antibiotic

NSC Number

None

Primary Site

Bladder

Histology

None

Remarks

April 15, 2020 The FDA approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system.

Coding

This drug should be coded
Glossary